Michael A Beckett Selected Research

4-hydroxyacetophenone

1/2020

4-Hydroxyacetophenone modulates the actomyosin cytoskeleton to reduce metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael A Beckett Research Topics

Disease

16	Neoplasms (Cancer) 12/2020 - 01/2002
4	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2002
3	Breast Neoplasms (Breast Cancer) 12/2020 - 04/2009
2	Necrosis 12/2011 - 09/2004
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Dehydration (Water Stress) 04/2015
1	Inflammation (Inflammations) 01/2012
1	Prostatic Neoplasms (Prostate Cancer) 07/2011
1	Lung Neoplasms (Lung Cancer) 04/2009
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2005
1	Carcinoma (Carcinomatosis) 09/2004
1	Lewis Lung Carcinoma 11/2002
1	Thrombosis (Thrombus) 02/2002
1	Infections 02/2002
1	Fibrosarcoma 01/2002

Drug/Important Bio-Agent (IBA)

3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012 - 02/2002
2	CytokinesIBA 06/2013 - 01/2012
2	Membrane LipidsIBA 12/2011 - 09/2004
2	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2009 - 09/2004
2	Oncogene Proteins (Oncogene Protein)IBA 04/2009 - 04/2009
2	Mucin-1 (CA 15-3 Antigen)IBA 04/2009 - 04/2009
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2005 - 11/2002
2	AngiostatinsIBA 11/2002 - 02/2002
1	ActomyosinIBA 01/2020
1	4-hydroxyacetophenoneIBA 01/2020
1	boron oxide (BO2)IBA 04/2015
1	Conditioned Culture MediaIBA 01/2012
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2011
1	veliparibIBA 07/2011
1	Type I Tumor Necrosis Factor ReceptorsIBA 05/2010
1	AntigensIBA 05/2010
1	Neoplasm Antigens (Tumor Antigens)IBA 05/2010
1	Interferon-betaIBA 05/2010
1	ChemokinesIBA 05/2010
1	CholesterolIBA 04/2009
1	Tamoxifen FDA LinkGeneric 04/2009
1	LipidsIBA 04/2009
1	Fatty Acids (Saturated Fatty Acids)IBA 04/2009
1	Estrogen Receptor alphaIBA 04/2009
1	Transcription Factors (Transcription Factor)IBA 04/2009
1	forphenicinolIBA 09/2005
1	Poloxamer (Poloxamer 407)IBA 09/2004
1	Surface-Active Agents (Surfactants)IBA 09/2004
1	Peptides (Polypeptides)IBA 01/2004
1	Proteins (Proteins, Gene)FDA Link 01/2004
1	Histones (Histone)IBA 01/2004
1	Complementary DNA (cDNA)IBA 02/2002
1	Plasminogen Activators (Plasminogen Activator)IBA 02/2002
1	Monoclonal AntibodiesIBA 01/2002
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2002

Therapy/Procedure

5	Radiotherapy 12/2020 - 01/2004
4	Therapeutics 01/2012 - 02/2002
1	Aftercare (After-Treatment) 07/2011